NORTHERN NEW JERSY COMMUNITY ONCOLOGY PROGRAM

新泽西州北部社区肿瘤学计划

• 批准号: 2894567
• 负责人: RICHARD J ROSENBLUTH
• 金额: $ 48.14万
• 依托单位: HACKENSACK UNIVERSITY MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 1983
• 资助国家: 美国
• 起止时间: 1983-09-01 至 2002-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2894567
• 关键词: antineoplastics; behavioral /social science research tag; cancer information system; cancer prevention; cancer registry /resource; cancer rehabilitation /care; cervical /vaginal smear; clinical research; clinical trials; community health services; continuing education; cooperative study; drug screening /evaluation; early diagnosis; health services research tag; human subject; human therapy evaluation; medical rehabilitation related tag; neoplasm /cancer education; neoplasm /cancer therapy; patient /disease registry; patient care management; pediatric neoplasm /cancer; pharmacy administration; primary care physician; prostate neoplasms

DESCRIPTION: (Applicant's Description) The Northern New Jersey CCOP (NNJCCOP) provides regional access to national cooperative group clinical trials to over 50% of the population of New Jersey as well as bordering New York. The NNJCCOP provides physician access to five research bases. Sixty physicians, including 25 medical oncologists, have access to studies in ECOG, NSABP, URCC a n d SWOG for the PCPT. Nineteen physicians, including 8 pediatric hematologists/oncologists, are members of POG. Eight physicians collaborate with both medical and pediatric oncologists. Altogether 71 physicians currently participate in the NNJCCOP. There are 6 clinical sites at 5 component hospitals in 5 cities: in Hackensack, the Hackensack University Medical Center (HUMC) has two clinical sites: the Tomorrows Children's Institute (TCI) and the Northern New Jersey Cancer Center (NNJCC); in Elizabeth, the Elizabeth General Medical Center (EGMC); in Morristown, the Morristown Memorial Hospital (MMH); in Summit, the Overiook Hospital (OH); and in Montclair, the Mountainside Hospital (MSH). The component hospitals access nearly 5000 newly diagnosed cancer patients a year and account for over 2500 hospital beds. The overall objective of this proposal is to reduce cancer incidence, morbidfty, and mortality by accelerating the transfer of newly developed cancer prevention, early detection, treatment, patient management, rehabilitation, and continuing care technology to widespread community application. There are several aims: to provide regional access to NCI-sponsored trials, to increase women and minorities, to expand NNJCCOP influence at the research bases, to maintain standards of excellence through quality assurance measures, and to enhance cancer control contributions through reaching more primary care physicians and specialists. The methods include a regional consortium of hospitals and investigators who are govened by an Executive Committee and coordinated through the NNJCCOP C o n s ortium Office; common approaches to recruitment, retention, and compliance; policies and procedures for protocol management, research records, and drug distribution; carefully designed and executed quality control and assurance measures. Staff assignments particularly focus on accruial to Bone Marrow Transplant studies, the BCPT, and the PCPT. Between 1997 and 2002, over 1300 CCOP credits or at least 272.9 CCOP credits a year are projected with 154.5 treatment credits and 118.4 cancer control credits.

描述：（申请人的描述）北方新泽西CCOP （NNJCCOP）提供区域访问国家合作组临床 试验超过50%的人口新泽西以及接壤的新 约克。 NNJCCOP为医生提供五个研究基地的访问权限。 六十 医生，包括25名医学肿瘤学家，可以获得 PCPT的ECOG、NSABP、URCC和SWOG。 19名医生，包括8名 儿科血液学家/肿瘤学家是POG的成员。 八位医生 与医学和儿科肿瘤学家合作。 共71 医生目前参加NNJCCOP。 在5个城市的5个组成医院设有6个临床站点： Hackensack，Hackensack大学医学中心（HUMC）有两个临床 地点：明日儿童研究所（TCI）和北方新泽西 癌症中心（NNJCC）;伊丽莎白，伊丽莎白综合医疗中心 （EGMC）;在莫里斯敦，莫里斯敦纪念医院（MMH）;在萨米特， Overlook医院（OH）;以及在蒙特克莱尔的Mountainside医院 （MSH）。 各组成医院访问近5000个新诊断的癌症 每年有超过2500张病床。 该提案的总体目标是减少癌症发病率， 疾病和死亡率，通过加速新开发的 癌症预防、早期发现、治疗、患者管理， 康复和持续护理技术，以广泛的社区 应用程序. 有几个目标：提供地区性的国家癌症研究所赞助的试验， 增加妇女和少数民族的人数，扩大NNJCCOP在 研究基地，通过质量保持卓越的标准 保证措施，并通过以下措施加强癌症控制贡献 覆盖更多的初级保健医生和专家。 这些方法包括一个由医院和研究人员组成的区域联盟， 由执行委员会管理，并通过NNJCCOP C进行协调 o n s ortium Office;招聘、保留和 合规性;方案管理、研究的政策和程序 记录和药物分发;精心设计和执行质量 控制和保证措施。 工作人员的任务特别侧重于 骨髓移植研究、BCPT和PCPT的累积费用。 1997年至2002年期间，超过1 300个CCOP学分或至少272.9个CCOP学分 每年预计有154.5个治疗信用和118.4个癌症控制信用 学分.